MENU
PULM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Pulmatrix (PULM) Ownership - Who owns Pulmatrix?
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
36 Crosby Drive
Phone
+1 781 357-2333
Employees
22
Web
https://www.pulmatrix.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
24.51M
P/E Ratio
N/A
Total Cash
10.78M
Projected Growth
N/A
Total Debt
N/A
Revenue
10.01M
Risk (Beta)
2.07
Dividend Yield
N/A
Total Cash/Share
2.95
Total Debt/Equity
N/A
Revenue/Share
2.14 USD as % of share price
Fundamentals
PULM
Capitalization
24.5M
P/E Ratio
N/A
Risk (Beta)
2.07
Dividend Yield
N/A
Total Cash
10.8M
Total Cash/Share
2.95
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.14%
Revenue
10M
ROE
N/A
Book Value
10.9M
P/B Ratio
2.74
Cash Flow
N/A
Earnings
-2.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
19.40
Current Revenue Per Employee
16636.36
Dividends Per Share - Security
N/A
EBITDA
-6.78M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-40.00
Shares Held By Institutions
2.65M
Shares Outstanding - Current
3.65M
Total Liabilities
590K
Total Volume MTD
N/A
Value
N/A
Gain YTD
-3.868
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceuticals for pulmonary disease
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
36 Crosby Drive
Phone
+1 781 357-2333
Employees
22
Web
https://www.pulmatrix.com